← Browse by Condition
Medical Condition
recurrent glioblastoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1
NCT04559230 Phase 2
Recruiting
Sacituzumab Govitecan in Recurrent Glioblastoma
Enrollment
32 pts
Location
United States
Sponsor
The University of Texas Health...
NCT05284643
Recruiting
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
Enrollment
96 pts
Location
United States
Sponsor
University of Miami
NCT07209241 Phase 1
Recruiting
Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM
Enrollment
12 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07480941 Phase 1
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
NCT06097975 Phase 1
Recruiting
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma
Enrollment
18 pts
Location
Belgium
Sponsor
Universitair Ziekenhuis Brusse...